BLG Group AI, achieve a better life

In the keynote speech of the annual conference, a number of industry leaders and group executives elaborated on the strategic planning of the group for the future of enzyme-based technology and enzyme-based industry.

• Professor Lu Fuping, Deputy Secretary of the Party Committee and President of Tianjin University of Science and Technology, who is also in charge of the Enzyme-based Science and Technology Innovation Research Institute, detailed the future development plans for the institute in his speech titled "Enzyme-based Science and Technology Leading Healthy Living, Innovative Research Institute Building an Integrated Industry-University-Research Platform." He pointed out, "Enzymes make the world better, because enzymes make everyone better." Professor Lu's speech highlighted the tremendous potential of enzyme-based technology in the health sector.
• Professor Dong Ping, Deputy Director of the China Financial Research Center at Shanghai Advanced Institute of Finance and Economics, Shanghai Jiao Tong University, and CEO of Shanghai Heju Ying Technology Co., Ltd., discussed whether life health could undergo fundamental changes due to enzyme-based AI. His speech sparked deep reflections among attendees on the application of AI technology in health management.
• In his speech on "Private Domain Membership and Health Services", Tao Wei, CEO of Krong Holdings, gave a detailed interpretation of the AI service system of Enjoy Life, emphasizing that "Only for you who join Enjoy Life to have a better life".
• Mr.Li Yichao, president of Rococo Innovation Design Group, emphasized the importance of enzyme-based categories to create new value in his speech "Users are the Future: Rebuilding Brand Vitality in the Wave of Big Health": "Behind the success of each brand is the creation of a new value category".
• In her speech "Qinghui Yue · New Product Launch: From Inside to Outside, Nourishing Cells", Jiang Hua, product manager of Qiyue, announced an important milestone for the group in the field of women's health —— two new products specially designed for women's health were officially released.

• CEO Mike Di of North America shared the progress in the North American market and mentioned that on the basis of the nine enzyme-based products listed in Canada, the group has added an enzyme-based product with NPN approval, further consolidating the group's position in the international market.
• "I firmly believe that natural health products can make more people healthier," said Dr. Ali, one of the first naturopathic doctors in Canada.
• Ken West, brand partner of North America, expressed his 100% confidence in BLG Group.

• Mr.Li Pengze, CEO of BLG International Business Division, announced the establishment of the international business division in his speech, which marked the deepening of the group's globalization journey: "This is a starting point from zero to one, and also the beginning of writing global dreams."
• In his speech "BLG Group, Mission Must Be Achieved", Mr.Chang Jiansheng, chief culture officer of Zhen Holdings, encouraged all employees: "Others can not decide your future, you will decide your future".
• Mr.Shijun Rong, Chief Operating Officer of Good Life Group and Zhen Holdings, emphasized in the "Zhen Holdings 2025 Operations Work Report" that "dreams, missions, and visions ultimately need to be translated into action." Standing at the new starting point of our sixth anniversary, we face a broader market and more intense competition. Only by being down-to-earth can we move steadily forward; only through action can we turn dreams into reality.

Working together: strategic signing, opening a new chapter of health

At the signing ceremony, Enzyme Life Group reached strategic cooperation with a number of partners, further expanding the group's layout in the field of health services.

• Yihao Internet Hospital has signed a strategic cooperation agreement on digital medicine with Haikou Orthopedics and Diabetes Hospital affiliated to Shanghai Sixth People's Hospital. The agreement aims to provide customers with more precise medical services, reduce the costs of chronic disease rehabilitation and management, and create a new benchmark for smart medical care.
• Shen Shi Holdings and Liaoning Xinqite Biotechnology Co., Ltd. jointly developed an eye health product matrix, focusing on eye care, immunity improvement and eye disease adjustment, to create an intelligent eye health product production line, to protect the "vision" of the people.
• Enzyme World Holdings has reached strategic cooperation with Jilin Mingxintang Biotechnology Co., LTD. and Baishan Changbaishan Ginseng Research Institute to create a series of ginseng products combining enzyme-based technology with traditional ginseng processing technology, and promote the innovative development of the ginseng industry.

 

These collaborations are not only the superposition of resources, but also the reconstruction of ecology, marking the further deepening and expansion of BLG Group in the field of health services.

Glory Blooming: Award ceremony, contribute to outstanding contributions

At the award ceremony, the group honored teams and individuals who made outstanding contributions to its development over the past year. These distinguished colleagues not only demonstrated exceptional professional skills and an innovative spirit in their respective positions but also profoundly embodied the core values of "Enzyme Good Model" through their actions. They consistently upheld "customerism" and "long-termism," meticulously practicing every detail of "Enzyme Good Model" in their work. Whether it was research breakthroughs, technological innovation, customer service, or market expansion, they injected a continuous stream of energy into the group's growth with a strong sense of responsibility and mission.

Enzyme Good Model: Cultural leadership and value creation

"Enzyme Good Model" is the core culture of BLG Group. It represents our sincerity to customers, our pursuit of quality, and our firm belief in the future of Enzyme Good. This annual meeting aims to build consensus and drive the group to continue leading with culture and creating value in the AI era, ensuring the synergy between organization and individuals. Through this celebration, we hope to further promote the "Enzyme Good Model" culture, inspiring more employees to strive for excellence in their work, with higher standards and a stronger sense of responsibility, collectively deepening the construction of BSS BLG Group Service System. By continuous efforts, we aim to safeguard the healthy living of our customers.

The six-year anniversary celebration of BLG Group is not only a summary of the brilliant achievements over the past six years but also an outlook on future development. We believe that with the deep integration of AI technology and enzyme-based technology, BLG Group will continue to lead innovation and development in the health service sector, achieving a better life for more people.